| 2024 | | Deep learning-based metastasis detection in patients with lung cancer to enhance reproducibility and reduce workload in brain metastasis screening with MRI: a multi-center study | 이다현 |
| 2024 | | Deep learning–radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients | 김철호, 노진, 유슬기, 허재성 |
| 2020 | | DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network | 이현우 |
| 2022 | | Diagnostic accuracy and safety of CT-guided percutaneous lung biopsy with a coaxial cutting needle for the diagnosis of lung cancer in patients with UIP pattern | 김다영, 박경주, 선주성, 유슬기 |
| 2024 | | Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study | 강석윤, 고영화, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2017 | | Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters | 고영화, 박성용, 이수진 |
| 2010 | | Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. | 소의영, 이잔디 |
| 2018 | | Diffusion-Weighted Imaging of Brain Metastasis from Lung Cancer: Correlation of MRI Parameters with the Histologic Type and Gene Mutation Status | 정우상 |
| 2017 | | Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer? | 최용원, 최진혁 |
| 2020 | | DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF-A expression | 고영화 |
| 2019 | | Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study | 노오규 |
| 2017 | | Effect of formalin fixation and tumour size in small-sized non-small-cell lung cancer: a prospective, single-centre study | 함석진 |
| 2021 | | Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study | 이현우 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2010 | | Emphysema as a risk factor for the outcome of surgical resection of lung cancer. | 박경주, 박광주, 박주헌, 선주성, 신승수, 이규성, 이성수, 정우영, 최호, 황성철 |
| 2018 | | ESE1 suppresses the growth, invasion and migration of human NSCLC cells and tumor formation in vivo | 김철호, 이복순 |
| 2000 | | Evaluation of an adrenal mass in a patient with lung cancer by FDG coincidence positron emission tomography using a dual-head gamma camera. | 박찬희, 윤석남 |
| 2005 | | Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. | 박광주, 신승수, 오윤정, 이기범, 한재호, 황성철 |
| 2021 | | Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer | 고영화, 한재호, 함석진 |
| 2006 | | Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. | 박광주, 박래웅, 박주헌, 신승수, 오윤정, 이규성, 최영화, 황성철 |
| 2005 | | False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases. | 윤석남, 윤준기, 조철우 |
| 2011 | | Fully covered, retrievable self-expanding metal stents (Niti-S) in palliation of malignant dysphagia: long-term results of a prospective study. | 김진홍, 신성재, 이광재, 이기명, 임선교 |
| 1999 | | Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs. | 서광욱 |
| 2023 | | GNAQ-Regulated ZO-1 and ZO-2 Act as Tumor Suppressors by Modulating EMT Potential and Tumor-Repressive Microenvironment in Lung Cancer | 은정우 |
| 2019 | | HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer | 김유선 |
| 2023 | | Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma | 고영화, 박범희, 이현우, 한재호, 함석진 |
| 2018 | | Indoor Radon and Lung Cancer: Estimation of Attributable Risk, Disease Burden, and Effects of Mitigation | 김시헌 |
| 2019 | | Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma | 신승수 |
| 2019 | | Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer | 고영화 |
| 2021 | | Interferon-γ-inducible chemokines as prognostic markers for lung cancer | 박광주, 박주헌, 박지은, 신승수, 이규성, 정우영, 정윤정 |
| 2019 | | Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas | 고영화, 이다근, 이수진 |
| 2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
| 2021 | | Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients? | 주영준 |
| 2024 | | Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset | 최진혁 |
| 2022 | | Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors | 권민석 |
| 2019 | | Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study | 김유찬 |
| 2015 | | Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04. | 최진혁 |
| 2007 | | Neutrophilic eccrine hidradenitis in non-small cell lung cancer. | 김유찬 |
| 2007 | | Nonionic intravenous contrast agent does not cause clinically significant artifacts to 18F-FDG PET/CT in patients with lung cancer. | 신승수, 안영실, 오윤정, 윤준기, 황성철 |
| 2014 | | Optimal set of grid size and angular increment for practical dose calculation using the dynamic conformal arc technique: a systematic evaluation of the dosimetric effects in lung stereotactic body radiation therapy. | 박혜진 |
| 2020 | | Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) | 안미선 |
| 2019 | | PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data | 고영화, 이수진, 이현우, 정준호, 한재호, 함석진 |
| 2020 | | Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07 | 안미선 |
| 2007 | | Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. | - |
| 2007 | | Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. | 장영주 |
| 2015 | | Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer. | 박광주, 박성용, 윤준기, 이수진 |
| 2017 | | Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy | 고영화, 이현우 |
| 2014 | | Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer | 노오규, 오영택 |
| 2019 | | Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma | 고영화, 한재호 |
| 2017 | | Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase | 고영화, 이수진 |
| 2022 | | Prognostic value of advanced lung cancer inflammation index in patients with colorectal cancer liver metastases undergoing surgery | 오승엽 |
| 2023 | | Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis | 박용진 |
| 2015 | | Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer. | 박성용 |
| 2019 | | Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice | 김유선 |
| 2021 | | Pulmonary Metastasectomy in Colorectal Cancer: A Population-Based Retrospective Cohort Study Using the Korean National Health Insurance Database | 유우식 |
| 2016 | | Q787Q EGFR Polymorphism as a Prognostic Factor for Lung Squamous Cell Carcinoma | 고영화 |
| 2016 | | Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer | 노오규, 박래웅, 박성용, 안미선, 오영택, 윤덕용, 이현우, 전미선, 최진혁, 허재성 |
| 2016 | | Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer | 노오규, 오영택, 이현우, 전미선, 조오연 |
| 2019 | | Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer | 최진혁 |
| 2015 | | Recurrence Risk-Scoring Model for Stage I Adenocarcinoma of the Lung. | 박성용 |
